Oncolytics Biotech (ONCY) Net Equity Issued and Repurchased (2009 - 2019)

Oncolytics Biotech's (ONCY) quarterly Net Equity Issued and Repurchased came in at $3.5 million in Q1 2019, up 208.71% on a QoQ basis from $1.1 million in Q3 2018.

Oncolytics Biotech (ONCY) Net Equity Issued and Repurchased (2009 - 2019) Analysis & Trends

Oncolytics Biotech (ONCY) has 4 years of Net Equity Issued and Repurchased data on file, last reported at $3.5 million in Q1 2019.

  • On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $3.5 million in Q1 2019; TTM through Sep 2025 was $3.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $3.1 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased for Q1 2019 stood at $3.5 million, up from $1.1 million in the prior quarter.
  • Over the last five years, Net Equity Issued and Repurchased for ONCY reached as high as $3.5 million in Q1 2019 and fell as low as $1.1 million in Q3 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 Oncolytics Biotech 372.40 Mn 372.40 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2019 3.53 Mn
Mar 31, 2019 3.53 Mn
Sep 30, 2018 1.14 Mn
Sep 30, 2018 1.14 Mn
Jun 30, 2010 66.32 Mn
Jun 30, 2010 66.32 Mn
Mar 31, 2010 66.32 Mn
Mar 31, 2010 66.32 Mn
Dec 31, 2009 66.32 Mn
Dec 31, 2009 66.32 Mn
Sep 30, 2009 66.32 Mn
Sep 30, 2009 66.32 Mn
Jun 30, 2009 52.45 Mn
Jun 30, 2009 52.45 Mn
Mar 31, 2009 46.28 Mn
Mar 31, 2009 46.28 Mn